Buy & Sell TransMedics Group Inc (TMDX) – TransMedics Group Inc Price Today
Aura AI Summary
Key Stats
- $2.29BMarket Cap
- TechnologySector
- -58.12%3M Drawdown
- $2.69BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 11 daysTypical Hold Time
TransMedics Group Inc (TMDX) is currently valued at a market capitalization of $2.29B, with an enterprise value of $2.69B. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Over the past three months, TransMedics Group Inc has recorded a drawdown of -58.12%, reflecting recent price volatility. On average, investors hold TransMedics Group Inc for approximately 11 days, indicating typical investor behavior on the platform.
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Most Recent News
US Golden Dome missile defense plan faces criticism over cost and arms race risks.
The US Golden Dome missile-defense system, designed to protect against ballistic, hypersonic, and cruise missiles, is under fire from Democrats and arms-control advocates. Critics warn it could cost over $1 trillion in 20 years, potentially trigger a...

Nike shares rise as energy prices fall and bond yields ease, boosting consumer stocks.
Nike's stock climbed over 4% following a drop in crude oil prices and a slight decrease in long-term Treasury yields, which eased borrowing costs and improved market sentiment. The retreat in energy prices and bond yields helped revive confidence in ...

ZIM reports Q1 sales drop 30% and adjusted EBITDA down 60% amid shipping market weakness
ZIM Integrated Shipping reported a 30% year-over-year sales decline to $1.40 billion in Q1 2026, missing expectations due to lower freight rates and an 8% drop in carried volume. Adjusted EBITDA fell 60% to $313 million with margins shrinking from 39...
